This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2018 Jul;179(1):224.

doi: 10.1111/bjd.16675. Epub 2018 May 8.

Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors

L Machet^{1

2}, J Zaragoza³, A Finon³, M Garnier², H Maillard⁴, A Caille^{5

6}

Affiliations

Affiliations

¹ Inserm U1253, University of Tours, Tours, France.
² Department of Dermatology, Tours, France.
³ Department of Dermatology, CHR Orléans, Orléans, France.
⁴ Department of Dermatology, CH Le Mans, Le Mans, France.
⁵ PRES Centre, Val de Loire University, University of Tours, Tours, France.
⁶ INSERM CIC 1415, CHRU Tours, Tours, France.

PMID: 29660775
DOI: 10.1111/bjd.16675

Comment

Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors

L Machet et al. Br J Dermatol. 2018 Jul.

. 2018 Jul;179(1):224.

doi: 10.1111/bjd.16675. Epub 2018 May 8.

Authors

L Machet^{1

2}, J Zaragoza³, A Finon³, M Garnier², H Maillard⁴, A Caille^{5

6}

Affiliations

¹ Inserm U1253, University of Tours, Tours, France.
² Department of Dermatology, Tours, France.
³ Department of Dermatology, CHR Orléans, Orléans, France.
⁴ Department of Dermatology, CH Le Mans, Le Mans, France.
⁵ PRES Centre, Val de Loire University, University of Tours, Tours, France.
⁶ INSERM CIC 1415, CHRU Tours, Tours, France.

PMID: 29660775
DOI: 10.1111/bjd.16675

No abstract available

PubMed Disclaimer

Comment on

Baseline neutrophil to lymphocyte ratio combined with serum lactate dehydrogenase level associated with outcome of nivolumab immunotherapy in a Japanese advanced melanoma population.
Fujisawa Y, Yoshino K, Otsuka A, Funakoshi T, Fujimura T, Yamamoto Y, Hata H, Tanaka R, Yamaguchi K, Nonomura Y, Hirai I, Furudate S, Okuhira H, Imafuku K, Aoki M, Matsushita S. Fujisawa Y, et al. Br J Dermatol. 2018 Jul;179(1):213-215. doi: 10.1111/bjd.16427. Epub 2018 Apr 24. Br J Dermatol. 2018. PMID: 29405254 No abstract available.
Baseline neutrophil-to-lymphocyte ratio in patients with advanced melanoma treated with immune checkpoint inhibitors: reply from the authors.
Fujisawa Y. Fujisawa Y. Br J Dermatol. 2018 Jul;179(1):224-225. doi: 10.1111/bjd.16689. Epub 2018 May 7. Br J Dermatol. 2018. PMID: 29733122 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information